Mesenteric Vascular Thromboembolism in Inflammatory Bowel Disease: A Single Center Experience

Journal of Gastrointestinal Surgery

Volumn 15, Issue 1, 2011, Pages 97-100

  Jackson, Christian S ^a   Fryer, Jonathan ^b   Danese, Silvio ^c   Vanagunas, Aryvdas ^b   Polensky, Sharon ^b   Buchman, Alan L ^b  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Crohn's disease; Inflammatory bowel disease; Mesenteric arterial thrombosis; Mesenteric venous thrombosis; Ulcerative colitis

Indexed keywords

EID: 78751572843     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1336-2     Document Type: Article

References (24)

1. Bargen JA, Barker BN. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936; 58(1): 17-31.
2. Bernstein CN, Wajda A, Blanchard JF et al. The incidence of arterial thrombotic disease in inflammatory bowel disease: a population-based study. Clin Gastro Hepatol 2008; 6(1): 41-5.
3. Miehsler W, Reinisch W, Valic E et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53: 542-548.
4. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85: 430-434.
5. Irving P, Pasi K, Rampton D. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005; 3(7): 617-628.
6. Solem CA, Loftus EV, Tremaine W, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004; 99(1): 97-101.
7. Irving PM, Alstead EM, Greaves RR et al. Acute mesenteric infarction: an important cause of abdominal pain in ulcerative colitis. Eur J Gastroenterol Hepatol 2005; 17: 1429-32.
8. Ha C, Magowan S, Accortt N, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009; 104: 1445-51.
9. Kaleya RN, Boley SJ. Aggressive approach to acute mesenteric ischemia. Surg Clin North Am 1992; 35(6): 613-23.
10. Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2007; 102: 174-86.
11. Geelkerken RH., van Bockel JH Mesenteric vascular disease: a review of diagnostic methods and therapies. Cardiovascular Surgery 1995; 3(3): 247-260.
12. Danese S, Katz JA, Saibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2004; 52: 1435-41.
13. Danese S, Sans M, Scaldaferri F, et al. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol 2006; 176: 2617-24.
14. Talbot RJ, Heppell J, Dozois R, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61(2): 140-145.
15. Irving P, Macey MG, Feakins R, et al. Platelet-leucocyte aggregates form i inthe mesenteric vasculature in patients with ulcerative colitis. Eur I Gastroenterol and Hepatol 2008, 20: 283-289.
16. Oldenburg B, Fijnheer R, van der Griend RR, et al. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 2000; 95: 2825-30.
17. Hatoum OA, Spinelli KS, Abu-Hajir M. et al. Mesenteric venous thrombosis in nflammatory bowel disease. J Clin Gastroenterol 2005; 39: 27-31.
18. Fichera A, Cicchiello LA, Mendelson DS, et al. Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain. Dis Colon Rectum, 2003; 46: 643-648.
19. Webberly MJ, Hart MT, Mehlikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993; 34(2): 247-51.
20. Collins CE, Rampton DS, Rogers J et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997; 9: 1213-17.
21. Liu Z, Colpaert S, D'Haens GR et al. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 1999; 163: 4049-4057.
22. Battaglia E, Biacene L, Resegotti A et al. Expression of CD40 and its ligand CD 40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol 1999; 94: 3279-3284.
23. Vogel JD, West GA, Danese S et al. CD40 mediated immune-non immune cells interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterlogy 2004; 126: 63-80.
24. Danese S, de la Motte C, Sturm A, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003; 124: 1249-64.